Literature DB >> 10189964

Gq signaling in cardiac adaptation and maladaptation.

G W Dorn1, J H Brown.   

Abstract

Accumulating evidence suggests that cardiac responses to a number of circulating or locally released humoral factors contribute to adaptive responses after hemodynamic stress or myocardial injury. In particular, hormones such as angiotensin II, endothelin 1, norepinephrine and prostaglandin F2 alpha which bind to and activate cardiomyocyte membrane receptors coupled to the Gq class of GTP binding proteins have been implicated in the development and ultimate decompensation of cardiac hypertrophy. Herein we summarize recent developments in cultured cardiomyocyte and transgenic mouse systems which are defining the phenotypes resulting from Gq signaling events in cardiomyocytes, and which are elucidating the critical downstream mediators. Postulated roles for protein kinase C, p38 MAP kinase and jun-N terminal kinase are discussed in relation to Gq-mediated cardiomyocyte hypertrophy and apoptotic signaling. The evidence to date suggests that molecular targeting of Gq or its effectors has the potential to modify cardiac adaptive and maladaptive responses to stress or injury.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10189964     DOI: 10.1016/s1050-1738(99)00004-3

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  43 in total

Review 1.  Cardiac hypertrophy and heart failure development through Gq and CaM kinase II signaling.

Authors:  Shikha Mishra; Haiyun Ling; Michael Grimm; Tong Zhang; Don M Bers; Joan Heller Brown
Journal:  J Cardiovasc Pharmacol       Date:  2010-12       Impact factor: 3.105

2.  Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy.

Authors:  T Taigen; L J De Windt; H W Lim; J D Molkentin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

Review 3.  Role of phospholipase Cε in physiological phosphoinositide signaling networks.

Authors:  Alan V Smrcka; Joan Heller Brown; George G Holz
Journal:  Cell Signal       Date:  2012-01-20       Impact factor: 4.315

Review 4.  Death begets failure in the heart.

Authors:  Roger S-Y Foo; Kartik Mani; Richard N Kitsis
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 5.  Mitogen-activated protein kinases in heart development and diseases.

Authors:  Yibin Wang
Journal:  Circulation       Date:  2007-09-18       Impact factor: 29.690

Review 6.  Nuclear and mitochondrial signalling Akts in cardiomyocytes.

Authors:  Shigeki Miyamoto; Marta Rubio; Mark A Sussman
Journal:  Cardiovasc Res       Date:  2009-03-11       Impact factor: 10.787

7.  The cardiac IP3 receptor: uncovering the role of "the other" calcium-release channel.

Authors:  Thomas J Hund; Andrew P Ziman; W J Lederer; Peter J Mohler
Journal:  J Mol Cell Cardiol       Date:  2008-06-13       Impact factor: 5.000

8.  Molecular mechanism of c-jun antisense gene transfection in alleviating injury of cardiomyocytes treated with burn serum and hypoxia.

Authors:  Yuesheng Huang; Angeng Hu
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

9.  Cardiac-specific overexpression of catalase identifies hydrogen peroxide-dependent and -independent phases of myocardial remodeling and prevents the progression to overt heart failure in G(alpha)q-overexpressing transgenic mice.

Authors:  Fuzhong Qin; Shannon Lennon-Edwards; Steve Lancel; Andreia Biolo; Deborah A Siwik; David R Pimentel; Gerald W Dorn; Y James Kang; Wilson S Colucci
Journal:  Circ Heart Fail       Date:  2009-12-16       Impact factor: 8.790

10.  Gene dosage-dependent effects of cardiac-specific overexpression of the A3 adenosine receptor.

Authors:  Richard G Black; Yiru Guo; Zhi-Dong Ge; Sidney S Murphree; Sumanth D Prabhu; W Keith Jones; Roberto Bolli; John A Auchampach
Journal:  Circ Res       Date:  2002-07-26       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.